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Background: There are several synergistic methods available. However, there is a vast discrepancy in the
interpretation of the synergistic results. Also, these synergistic methods do not assess the influence the tested
components (drugs, plant and natural extracts), have upon one another, when more than two components are
combined.
Methods: A modified checkerboard method was used to evaluate the synergistic potential of Heteropyxis natalensis,
Melaleuca alternifolia, Mentha piperita and the green tea extract known as TEAVIGO™. The synergistic combination
was tested against the oral pathogens, Streptococcus mutans, Prevotella intermedia and Candida albicans. Inhibition
data obtained from the checkerboard method, in the form of binary code, was used to compute a logistic response
model with statistically significant results (p < 0.05). This information was used to construct a novel predictive
inhibition model.
Results: Based on the predictive inhibition model for each microorganism, the oral pathogens tested were
successfully inhibited (at 100% probability) with their respective synergistic combinations. The predictive inhibition
model also provided information on the influence that different components have upon one another, and on the
overall probability of inhibition.
Conclusions: Using the logistic response model negates the need to ‘calculate’ synergism as the results are
statistically significant. In successfully determining the influence multiple components have upon one another and
their effect on microbial inhibition, a novel predictive model was established. This ability to screen multiple
components may have far reaching effects in ethnopharmacology, agriculture and pharmaceuticals.
Keywords: Synergism, Oral pathogens, Checkerboard method, Heteropyxis natalensis, Melaleuca alternifolia, Mentha
piperita, TEAVIGO™Background
Synergistic interaction between components i.e. drugs,
plant and natural extracts can enhance their efficacy and
bioactivity against a target. Furthermore, synergy reduces
toxicity, lowers the dosage and decreases adverse side
effects, as well as combating antimicrobial resistance [1,2].
Several synergistic methods and the methods used to
calculate synergy, have been reviewed [3]. However, there* Correspondence: namrita.lall@up.ac.za
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article, unless otherwise stated.appears to be vast discrepancies in the interpretation of
synergistic results.
There is also limited information available with regards
to assessing the influence multiple components have upon
one another in combination. Three-component combina-
tions have been proven successful in enhancing bioactivity
[4-8]. However, the more components added in combin-
ation, the more difficult it becomes to assess the influence
these components have upon each other’s bioactivity. The
overall influence of the combination against the selected
target would also be affected. This investigation aims to
use ‘a statistical approach that would allow for a more
reliable and qualitative assessment of pharmacologicalentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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upon one another and their effect on microbial inhib-
ition were also investigated.
An indigenous South African plant, Heteropyxis nata-
lensis was combined with the essential oils of Melaleuca
alternifolia and Mentha piperita as well as the green tea
extract known as TEAVIGO™. Combinations of these
were used against the oral pathogens, Streptococcus
mutans, Prevotella intermedia and Candida albicans [9].
Methods
Plant material
Aerial plant parts, comprising of leaves and twigs of H.
natalensis was collected. The plant parts were collected
from the University of Pretoria’s experimental farm during
January, 2013. A voucher specimen was prepared and
identified at the H.G.W.J. Schwelcherdt Herbarium (PRU),
University of Pretoria. Melaleuca alternifolia essential oil
(Holistic Emporium cc, Gauteng, South Africa), Mentha
piperita essential oil (Holistic Emporium cc, Gauteng,
South Africa), and TEAVIGO™ (Chempure (Pty) Ltd,
Silverton, South Africa), were purchased for the present
investigation.
Preparation of extract
The plant material was air dried at room temperature
(25°C), and ground to a fine powder using a standardFigure 1 Growth indicator, PrestoBlue, in the presence of Prevotella in
and Melaleuca alternifolia with Plate B additionally containing TEAVIGO™. B
indicated growth of P. intermedia.food processor. The powdered material was extracted
with ethanol (Merck Chemicals (Pty) Ltd Wadeville,
South Africa) under pressure (100 bar) and regulated
temperature of 50°C in a BUCHI Speed Extractor, E-916
(BUCHI Labortechnik AG, Switzerland). The solvent
was evaporated at low boiling point in a Genevac, EZ-2
plus (Genevac SP Scientific, UK), after which the extract
was subjected to antimicrobial tests.
Microbial strains
The microorganisms used in this study included Prevotella
intermedia (ATCC 25611), Streptococcus mutans (ATCC
25175) and Candida albicans (ATCC 10231). The bacteria
were grown on Casein-peptone Soymeal-peptone (CASO)
Agar (Merck Chemicals (Pty) Ltd Wadeville, South Africa)
enriched with 1% sucrose (Merck Chemicals (Pty) Ltd
Wadeville, South Africa) under anaerobic conditions in an
anaerobic jar with Anaerocult® A (Merck Chemicals (Pty)
Ltd Wadeville, South Africa), at 37°C for 48 hours.
Candida albicans was grown on Sabouraud Dextrose 4%
Agar (SDA) (Merck Chemicals (Pty) Ltd Wadeville, South
Africa), at 37°C for 48 hours. Sub-culturing was done
every second week. Inocula were prepared by suspending
microbial test organisms in their respective broths until
turbidity was compatible with McFarland Standard 1
(Merck Chemicals (Pty) Ltd Wadeville, South Africa)
[10]. Therefore, the colony forming units (CFU/ml) fortermedia. Plates A and B contained the essential oils Mentha piperita
lue-green indicated inhibition of Prevotella intermedia, while pink-red
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107 (CFU/ml) and C. albicans was 4 × 107 (CFU/ml) for
each bioassay.
Antimicrobial susceptibility testing
To determine the effects of combinations of H. natalensis,
M. alternifolia essential oil, M. piperita essential oil and
TEAVIGO™, the minimum inhibitory concentration (MIC)
of each component was determined first using the anti-
microbial microtiter-plate method [11]. A stock solution
of the ethanol extract of H. natalensis was prepared in
20% dimethyl sulphoxide (DMSO) (Merck Chemicals (Pty)
Ltd); while TEAVIGO™ was dissolved in distilled water.Figure 2 The checkerboard results for Prevotella intermedia. A 0 indica
contained Mentha piperita and Heteropyxis natalensis, while plate B had the
contained Melaleuca alternifolia and H. natalensis with TEAVIGO™ present in
M. alternifolia with Plate F additionally containing TEAVIGO™. Plates G and
M. piperita in plate H. The MIC’s for each component are also given.The stock solutions were serially diluted in enriched
CASO broth (Merck Chemicals (Pty) Ltd) for the bacteria
and Sabouraud Dextrose 4% broth (Merck Chemicals (Pty)
Ltd) for Candida; in the 96-well microtiter-plate adding
100 μl of a McFarland Standard 1 inoculum of 48 hour old
microorganisms grown at 37˚C. The final concentration of
the extract and TEAVIGO™ ranged from 0.10–12.5 mg/ml
and the positive control, 1.25% v/v chlorhexidine gluco-
nate (CHX) (Dental Warehouse, Sandton, South Africa),
ranged from 4.77 × 10−6–0.31% v/v. The essential oils were
dissolved in 10% Tween (80) (Merck Chemicals (Pty) Ltd
Wadeville, South Africa). The final concentration tested of
the essential oils ranged from 1.6 × 10−5–1.25% v/v. Theted no inhibition while 1 represented inhibition. Plates A and B
addition of the third component, TEAVIGO™. Plates C and D
plate D. Plates E and F contained the essential oils M. piperita and
H contained M. alternifolia and H. natalensis with the addition of
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Tween 80 (2%) were found to be non-toxic to the microor-
ganisms tested. The inoculated plates were incubated at
37°C, under anaerobic and aerobic conditions respectively
for 24 hours before adding 20 μl of the colour indicator
PrestoBlue [12]. The MIC was defined as the lowest con-
centration that inhibited the colour change of PrestoBlue.
Synergistic assay
The synergistic activity of the samples was determined
using a modified checkerboard method. The basic design
is a logarithmic design with the dosages halved at each
step. Full 2-factor factorial designs were used for twoFigure 3 The checkerboard results for Candida albicans. A 0 indicated
Mentha piperita and Heteropyxis natalensis, with plate B having the addition
D contained Melaleuca alternifolia and H. natalensis with TEAVIGO™ present
and M. alternifolia with Plate F additionally containing TEAVIGO™. Plates G
M. piperita in plate H. The MIC’s for each component are also given.factors at a time with equally spaced dosages for the other
factors. The individual designs were compounded in such
a way that all two-way interactions and some three-way
interactions could be estimated. Two 96-well plates were
prepared: the first one was used to make two-fold serial
dilutions of H. natalensis (50 μl) in horizontal orientation,
and the second plate, was used to make five-fold serial
dilutions of M. alternifolia in the vertical orientation. Both
dilutions were made in enriched CASO broth for the
selected bacteria, and Sabouraud Dextrose 4% broth for
the yeast, C. albicans. For the two-fold dilutions, 50 μl of
broth was pipetted per well for the first plate and 200 μl
for the five-fold dilutions in the second plate. Using ano inhibition while 1 represented inhibition. Plates A and B contained
of the third component, TEAVIGO™ (5 mg/ml). Plates C and
in plate D. Plates E and F contained the essential oils M. piperita
and H contained M. alternifolia and H. natalensis with the addition of
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ferred to the first plate, 50 μl of the respective broth was
added and then 50 μl of bacterial suspension was added to
each well and incubated for 24 h at 37°C; after which 20 μl
of PrestoBlue was used to indicate bacterial growth
[12,13]. The concentration range of H. natalensis in com-
bination ranged from 0.097 – 12.5 mg/ml, while the essen-
tial oils ranged from 1.6 × 10−5 – 1.25% v/v.
A third plate was prepared at the same time in the
exact same manner as the first plate except that instead
of 50 μl of additional broth; 50 μl of a third component,
M. piperita was added at a sub-MIC value at a fixed
concentration to all wells. The sub-MIC concentrationsFigure 4 The checkerboard results for Streptococcus mutans. A 0 indic
contained Mentha piperita and Heteropyxis natalensis were paired, with plat
C and D contained Melaleuca alternifolia and H. natalensis with TEAVIGO™ p
M. piperita and M. alternifolia with Plate F additionally containing TEAVIGO™
addition of M. piperita in plate H. The MIC’s for each component are also gof M. piperita and TEAVIGO™ were determined on the
basis of MIC values previously obtained.
This process was repeated for all the combinations of
the four components for each microorganism tested.
The MIC’s of each component tested (as previously
described) were also conducted at the same time acting as
controls and a comparison. The concentration range of
H. natalensis and TEAVIGO™ ranged from 0.097 – 12.5 mg/
ml, while the essential oils ranged from 1.6™ 10−5 – 1.25% v/
v. CHX was again utilized as a positive control.
Once the plates were developed with PrestoBlue, each
well was assigned either a 0 to indicate no inhibition or
a 1 to indicate inhibition for the logistic response model.ated no inhibition while 1 represented inhibition. Plates A and B
e B having the addition of the third component, TEAVIGO™. Plates
resent in plate D. Plates E and F contained the essential oils
. Plates G and H contained M. alternifolia and H. natalensis with the
iven.




Y 0 267 17 94.0
1 20 336 94.4
Overall Percentage 94.2
Table 3 Variables in the equation for Prevotella
intermedia
Ba S.E.b Sig.c
X1 .662 .072 .000
X2 82.473 11.501 .000
X3 60.709 7.536 .000
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inhibition model (IBM© SPSS© version 22) for each
microorganism where the antimicrobial ability of the
different combinations was tested as described in the
antimicrobial susceptibility testing [11].
Results
Antimicrobial susceptibility testing
The checkerboard method was utilized as a screening tool
for the reduction of MIC values. This method also pro-
vided numerous concentration variables for the compo-
nents under investigation and their inhibition potential
(Figure 1). The results were converted to binary code; with
0 representing no inhibition (pink-red), and 1 representing
inhibition (blue). This data was then used to compute the
logistic response model.
In determining the antimicrobial susceptibility of P. inter-
media (Figure 2), the addition of TEAVIGO™ (2.5 mg.ml)
to plate B (of paired plates A and B) reduced the MIC of
H. natalensis from 12.5 mg/ml to 3.13 mg/ml and that of
M. piperita from 1.17% v/v to 0.29% v/v. In plates C and D
the addition of TEAVIGO™ seemed to have little effect on
either H. natalensis or M. alternifolia; however, when
TEAVIGO™ was added to the essential oils, M. piperita
and M. alternifolia (plates E and F) both essential oils MIC’s
were reduced from 1.17% v/v to 0.29% v/v overall. In
plates G and H with H. natalensis and M. alternifolia
and the addition of M. piperita in plate H there was a
significant decrease in both components MIC’s. Even
though the pattern of inhibition to no-inhibition was a little
scattered, the overall reduction of the MIC of H. natalensis
from 12.5 mg/ml to 1.56 mg/ml and for M. alternifolia
from 1.17% v/v to 4.5 × 10−3% v/v was obtained. There is a
significant increase in the antimicrobial activity of the
components in combination when compared to the MIC
values of the individual components.
With C. albicans (Figure 3), the addition of TEAVIGO™
at a sub-MIC (5 mg/ml) in plate B, reduced the MIC of
H. natalensis from 12.5 mg/ml to 3.13 mg/ml but had no
impact on the MIC of M. piperita. The MIC of H. natalensis
was again reduced in plate D and the essential oil
M. alternifolia was also reduced from 1.17% v/v to
0.29% v/v. There was virtually no difference in plates E and F
containing M. alternifolia and M. piperita with the addition
of TEAVIGO™. The addition of M. piperita in plate H
reduced the MIC of M. alternifolia from 0.29% v/v to
0.07% v/v but had no effect on the MIC of H. natalensis.Table 1 Logistic model summary for Prevotella intermedia
-2 Log likelihood Nagelkerke R squarea
215.765 .864
aThe Nagelkerke R Square is the logistic regression equivalent of the usual
coefficient of determination used in multiple linear regression [16].Heteropyxis natalensis on its own inhibited C. albicans
at 8.33 mg/ml; in combination with M. piperita and
TEAVIGO™ this concentration was reduced to 3.13 mg/
ml. Melaleuca alternifolia in combination with H. natalensis
and M. piperita reduced the MIC from 0.24% v/v (of M.
alternifolia on its own) to 0.07% v/v.
In determining the inhibitory effect of three compo-
nents on S. mutans (Figure 4), there was a reduction in
the MIC of H. natalensis from 3.13 mg/ml to 1.56 mg/
ml with the addition of TEAVIGO™ but there was no
effect on M. piperita (plates A and B). The same effect
was exhibited with H. natalensis, M. alternifolia and the
addition of TEAVIGO™ in plates C and D. There was no
apparent effect of TEAVIGO™ on the essential oils, M.
piperita and M. alternifolia (plates E and F). There was
a marked increase in the inhibition by M. alternifolia
with the addition of M. piperita; from 1.17% v/v to
0.02% v/v (plates G and H). Melaleuca alternifolia on its
own inhibited S. mutans at 0.29%. In combination with
H. natalensis and M. piperita this inhibitory concentra-
tion was reduced to 0.02% v/v.
Logistic response model
The logistic response model [14] was used to predict the
probability associated with each value of the binary
response (Tables 1, 2, 3, 4, 5, 6, 7, 8 and 9). A stepwise
procedure [15] was used to select the most important
predictors. In this investigation the probability of inhib-
ition was modeled.X4 1.068 .220 .000
X1 by X3 −4.795 .690 .000
X3 by X4 35.518 18.520 .055




Table 4 Logistic model summary for Candida albicans
-2 Log likelihood Nagelkerke R square
92.432 .947
Table 6 Variables in the equation for Candida albicans
Ba S.E.b Sig.c
X1 3.488 .852 .000
X2 770.772 207.145 .000
X3 773.135 212.726 .000
X4 5.946 1.620 .000
X1 by X3 −61.807 17.021 .000
X2 by X4 −116.903 32.381 .000
X3 by X4 −4.824 2.252 .032
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Y = 0 means no response
Y = 1 means inhibition
X = (X1,X2,X3,X4) is the combination of dosages with
X1 representing H. natalensis, X2 - M. alternifolia, X3 -
M. piperita and X4 - TEAVIGO™
p(X) = the probability of inhibition given the dosage
combination
O(X) is the odds of obtaining inhibition
O Xð Þ ¼ p Xð Þ
1−p Xð Þ
The log(odds) is LN{O(X)}
The logistic regression model is a linear model (linear
in terms of the regression coefficients) that links the log
(odds) to the dosages and to interaction terms between
the dosages.
The function is estimated by means of maximum like-
lihood. In this case (Table 3), the estimate is
LN O Xð Þf g ¼ − 6:1þ 0:662X1 þ 82:473X2
þ 60:709X3 þ 1:068X4 − 4:795X1X3
þ 35:518X3X4
The estimated odds of inhibition is then
O Xð Þ ¼ EXP LN O Xð Þð Þð Þ ¼ eLN O Xð Þð Þ
The estimated probability of inhibition is then
p Xð Þ ¼ O Xð Þ
1þ O Xð Þ
Validation of the models
With the variables in the equation for Prevotella
intermedia (Table 3), 80% of the original sample was
randomly selected to be the training sample, and the
remaining 20% formed the test sample. The model was
fitted using the training sample and used to predict the




Y 0 268 9 96.8
1 13 350 96.4
Overall percentage 96.6outcome was that 92.4% of the training sample was
correctly classified and 95.4% of the validation sample
was correctly classified. This is considered satisfactory.
With the variables in the equation for Candida albicans
(Table 6), 80% of the original sample was randomly
selected to be the training sample, and the remaining
20% formed the test sample. The model was fitted using
the training sample and used to predict the outcomes of
the training and validation samples. The outcome was
that 96.8% of the training sample was correctly classified
and 95.7% of the validation sample was correctly classi-
fied. This is considered satisfactory.
With the variables in the equation for Streptococcus
mutans (Table 9), 80% of the original sample was ran-
domly selected to be the training sample, and the
remaining 20% formed the test sample. The model was
fitted using the training sample and used to predict the
outcomes of the training and validation samples. The
outcome was that 92.7% of the training sample was
correctly classified and 96.7% of the validation sample
was correctly classified. This is considered satisfactory.
Predictive inhibition model
A maximum of three components were tested on a micro-
titre plate using the modified checkerboard method. All
possible combinations of the four components were tested
this way (Figure 2). The log odds estimate, LN{O(X)},
obtained from the logistic regression model, combines the
data of the four components in the predictive inhibition
model. This enabled the probability of inhibition to be cal-
culated utilizing all four components. The predictive inhib-
ition model also provided information on the influence,Table 7 Logistic model summary for Streptococcus mutans
-2 Log likelihood Nagelkerke R square
162.446 .900




Y 0 251 13 95.1
1 23 353 93.9
Overall percentage 94.4
Table 10 The influence each component had on the













3.125 0.05 0.05 0.915183
3.125 0.05 0.05 5 1.000000
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and on the probability of inhibition (Table 10).
Tables 10, 11 and 12, show further validation of the pre-
dictive models for each microorganism tested. The models
were used to predict the probability of inhibition outside
the experimental area, and additional experiments were
performed in the laboratory to judge the performance of
the models. The performance was satisfactory.
Based on the predictive inhibition model where 1 indi-
cates the probability for 100% inhibition; P. intermedia
(Table 11), C. albicans (Table 12) and S. mutans (Table 13)
were successfully inhibited. At probabilities lower than
100% almost no inhibition was obtained for P. intermedia
and C. albicans, while there was inhibition of S. mutans at
99%. Prevotella intermedia seemed to be sensitive to
the concentration of M. alternifolia, as no inhibition was
obtained when M. alternifolia was decreased to 0.01% v/v
(at a 99.8% probability).
There is a reduction in the MIC values of the individual
components, when used in combination for each of the
microorganisms tested (Table 14). And therefore, we can
state that there is an overall increase in the inhibitory
activity when the components are used in combination.
Discussion
The synergistic combination of the components had differ-
ent effects on each of the microorganisms tested. This may
indicate the possible mechanism of action of these compo-
nents. The combinations of M. piperita, H. natalensis and
TEAVIGO™, against P. intermedia, C. albicans and S.Table 9 Variables in the equation for Streptococcus
mutans
Ba S.E.b Sig.c
X1 2.249 .253 .000
X2 34.504 5.160 .000
X3 55.328 7.499 .000
X4 12.302 2.154 .000
X1 by X3 −5.628 .791 .000
Constant −6.086 .666 .000
aRegression Co-efficient.
bStandard Error.
cSignificance.mutans all had similar outcomes, resulting in an increased
H. natalensis activity against these microorganisms (plates
A and B of Figures 2, 3 and 4). The combination of
M. alternifolia, H. natalensis and TEAVIGO™ (plates C and
D) resulted in an increase in the activity of H. natalensis
against S. mutans and both H. natalensis and M. alternifolia
against C. albicans. However, this combination had no
apparent effect on P. intermedia. The reverse situation oc-
curred for the combination of M. piperita, M. alternifolia
and TEAVIGO™ (plates E and F), where an increase in
antimicrobial activity was noted for M. piperita and M.
alternifolia on P. intermedia but there were no noticeable
effects on C. albicans and S. mutans. Both Gram-positive
and Gram-negative bacteria's cell walls consist of peptido-
glycan. Peptidoglycan is comprised of N-acytyl-muramic
acid and N-acetyl-glucosamine cross linked by peptide side
chains and cross-bridges; however, peptidoglycan is thicker
in Gram-positive bacteria. Gram-negative bacteria also
possess a periplasmic space which lies between the outer
membrane and the cytoplamic membrane. It is within this
space that some Gram-negative bacteria produce the
lactamase enzyme that can resist drugs such as penicillin
[17]. The combination of M. piperita, M. alternifolia and
TEAVIGO™ may target the transenvelope efflux pump in
P. intermedia which does not occur in S. mutans or the
eukaryotic C. albicans [18]. The combination of M. piperita,
M. alternifolia and H. natalensis (plates G and H) all re-
sulted in an increase in M. alternifolia antimicrobial
activity but only on P. intermedia was the activity of
H. natalensis also increased. Overall it would seem that
TEAVIGO™ increases the antimicrobial inhibitory activity
of H. natalensis; while M. piperita has a similar effect on
its essential oil counterpart M. alternifolia.
The predictive inhibition model provides information
of the influence the different components tested have
upon one another and on the probability of inhibition.
This ‘determination of influence’ goes beyond the classi-
fication of synergism, indifference and antagonism. A
probability of inhibition value was assigned to the con-
centration of each individual component and in various
combinations of two to four. The concentrations of each
component can then be adjusted to obtain a 100% prob-
ability of inhibition. The predictive inhibition model is
Table 11 Predictive model showing the probability of













0.78125 0.002 0.002 1.25 0.02023 No
inhibition
1.5625 0.002 0.01 1.25 0.06981 No
inhibition
1.5625 0.01 0.01 1 0.09233 No
inhibition
1.5625 0.01 0.01 2.5 0.46238 No
inhibition
3.125 0.01 0.05 2.5 0.99795 No
inhibition
3.125 0.05 0.05 2 0.99969 Inhibition
3.125 0.05 0.05 5 1.00000 Inhibition
6.25 0.05 0.25 5 1.00000 Inhibition
6.25 0.25 0.25 4 1.00000 Inhibition
Table 13 Predictive model showing the probability of













0.390625 0.00008 0.0004 0.390625 0.40661 No
inhibition
0.390625 0.0004 0.0004 0.390625 0.40928 No
inhibition
0.390625 0.002 0.002 0.390625 0.44355 No
inhibition
0.78125 0.0004 0.002 0.78125 0.99549 Inhibition
0.78125 0.002 0.002 0.78125 0.99573 Inhibition
0.78125 0.01 0.01 0.78125 0.99784 Inhibition
1.5625 0.002 0.01 1.5625 1.00000 Inhibition
1.5625 0.01 0.01 1.5625 1.00000 Inhibition
1.5625 0.05 0.05 1.5625 1.00000 Inhibition
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from the logistic response model. This has reduced the
need to calculate the fractional inhibitory concentration
(FIC) or equivalent values.
There is a reduction in the MIC values of each individ-
ual component, when used in combination for each of
the microorganisms tested (Table 14). Therefore, we can
state that there is an overall increase in the inhibitory
activity when the components are used in combination.
Conclusions
The use of the checkerboard method as a screening
tool, utilizing the binary code to indicate inhibitionTable 12 Predictive model showing the probability of













0.78125 0.002 0.002 2.5 0.00000 No
inhibition
1.5625 0.002 0.01 2 0.00000 No
inhibition
1.5625 0.01 0.01 2 0.00003 No
inhibition
1.5625 0.01 0.01 5 0.97528 No
inhibition
3.125 0.01 0.05 4 1.00000 Inhibition
3.125 0.05 0.05 4 1.00000 Inhibition
3.125 0.05 0.05 10 1.00000 Inhibition
6.25 0.05 0.25 8 1.00000 Inhibition
6.25 0.25 0.25 8 1.00000 Inhibitionand no inhibition and the input of those results into a
logistic response model, lead to the successful con-
struction of a predictive inhibition model. The predict-
ive model not only gives the probability of 100%
inhibition; but also shows the influence of those com-
ponents upon one another and their ability to inhibit
microbial growth.
The applications of this technique are almost limitless.
Not only can the inhibitory effect of different plants in
combinations of more than two be determined; new mul-
tiple drug combinations can be screened too. In ethno-
pharmacology, where the remedies of traditional healers
are tested this technique will also be useful as the healers
often use combinations of a variety of different plants for a
treatment. In Agriculture new pesticides can also be
screened as the combination of multiple components
leads to the slower development of resistance.Table 14 Comparison of the minimum inhibitory
concentrations of the tested components, individually
and in combination, after utilizing the predictive model
P. intermedia C. albicans S. mutans
Alonea Combob Alonea Combob Alonea Combob
H. natalensis
(mg/ml)
12.50 3.13 8.33 3.13 2.60 0.78
TEAVIGO™
(mg/ml)
>12.5 2.00 10.42 4.00 1.30 0.78
M. piperita
(% v/v)
0.20 0.05 0.10 0.05 0.10 2 × 10−3
M. alternifolia
(% v/v)
0.29 0.05 0.24 0.01 0.29 4 × 10−4
aComponent tested individually.
bComponents tested in combination.
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ATCC: American type culture collection; CASO: Casein-peptone Soymeal-peptone;
CFU: Colony forming units; CHX: Chlorhexidine gluconate; DMSO: Dimethyl
sulphoxide; FIC: Fractional inhibitory concentration; MIC: Minimum inhibitory
concentration; PRU: H.G.W.J. Schwelcherdt Herbarium; v/v: Volume per volume.
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